NFKB1 and cancer: Although the canonical nuclear factor-kappa B (NF-κB) pathway activated through inhibitor of kappa B kinase-β (IKKβ) blocks terminal differentiation of myogenic cells15, 16, in the context of cancer cachexia stimulation of NF-κB promotes the expansion of satellite cells17.